duloxetine hydrochloride has been researched along with Cognitive Decline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Danduga, RCSR; Kola, PK; Meejuru, GF; Nissankara Roa, LS; Somavarapu, A | 1 |
| Navratilova, E; Phelps, CE; Porreca, F | 1 |
| Begley, A; Butters, MA; Koenig, AM; Ogbagaber, S; Reynolds, CF; Wahed, AS | 1 |
3 other study(ies) available for duloxetine hydrochloride and Cognitive Decline
| Article | Year |
|---|---|
Protective effects of duloxetine against chronic immobilisation stress-induced anxiety, depression, cognitive impairment and neurodegeneration in mice.
Topics: Animals; Antioxidants; Behavior, Animal; Catalase; Cognitive Dysfunction; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Excitatory Amino Acid Antagonists; Glutathione; Mice; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Psychotropic Drugs; Superoxide Dismutase; Treatment Outcome | 2021 |
Chronic Pain Produces Reversible Memory Deficits That Depend on Task Difficulty in Rats.
Topics: Animals; Chronic Pain; Cognitive Dysfunction; Disease Models, Animal; Duloxetine Hydrochloride; Male; Neuralgia; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Serotonin and Noradrenaline Reuptake Inhibitors | 2021 |
Response to antidepressant medications in late-life depression across the spectrum of cognitive functioning.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Citalopram; Cognitive Dysfunction; Cyclohexanols; Dementia; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2014 |